Jilin Jian Yisheng Pharmaceutical002566.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Jilin Jian Yisheng Pharmaceutical (002566.SZ) trades at a P/E of 61.00x, P/B of 1.02x, P/S of 3.35x, and a dividend yield of 1.17%.
Longitudinal percentile comparison: P/E sits at the 75th percentile over the trailing 10Y window (vs. 54th percentile over 3Y); P/B sits at the 12th percentile over the trailing 10Y window (vs. 33rd percentile over 3Y); P/S sits at the 67th percentile over the trailing 10Y window (vs. 40th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 67th percentile within its industry and the 66th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.17%, ranking at the 86th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 63.3 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Jilin Jian Yisheng Pharmaceutical operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 002566 · SZSE: 002566 · 002566
Want the full picture on whether Jilin Jian Yisheng Pharmaceutical (002566.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 61.00 | ||||||
| P/B (MRQ) | 1.02 | ||||||
| P/S (TTM) | 3.35 | ||||||
| Dividend Yield | 1.17% | ||||||
| Buyback + Div Yield | 1.17% |